Loading clinical trials...
Loading clinical trials...
A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Warfarin in Healthy Male and Female Adults
Conditions
Interventions
PA21
Warfarin
Locations
1
United States
PRA International - Clinical Pharmacology Center
Lenexa, Kansas, United States
Start Date
November 1, 2011
Primary Completion Date
February 1, 2012
Completion Date
February 1, 2012
Last Updated
February 16, 2012
NCT03801746
NCT02191358
NCT01324752
Lead Sponsor
Vifor Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions